Although pneumococcal polysaccharide vaccine is a standard preventive intervention — and serves as a "quality indicator" in some settings — controversy over its effectiveness simmers in the ...

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...

which is a polysaccharide vaccine. The initials stand for pneumococcal polysaccharide vaccine, which protects against 23 strains. A polysaccharide vaccine is designed to prompt immunity by ...

Advisory Committee on Immunization Practices (ACIP) has lowered the recommended age for pneumococcal vaccination from 65 to ...

You have a good eye. This past fall, the Centers for Disease Control and Prevention changed the recommended age for getting the vaccine for pneumococcal pneumonia from those 65 and older to those ...

polysaccharide-based jab Pneumovax 23. Sanofi's new challenger is billed as a "next-generation" pneumococcal conjugate vaccine that, according to the company, is the first candidate with more than ...

The development by Wyeth of the vaccine Prevnar, as well as being a commercial success, was also a technological triumph. Conceptually, the approach was not new; pneumococcal polysaccharide ...

Dominance of the pneumococcal vaccine category is a race between ... which covers 23 serotypes but is based on an older polysaccharide technology that does not stimulate the immune response ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended four novel medicines for approval at its ...

Pregnant patients in their third trimester and postpartum women showed higher risk for IPD compared with nonpregnant patients.

You have a good eye. This past fall, the Centers for Disease Control and Prevention changed the recommended age for getting the vaccine for pneumococcal pneumonia from those 65 and older to those 50 ...